World's Best Scientists 2026 revealed!
Journal of Cardiovascular Pharmacology and Therapeutics
H-index 16

Journal of Cardiovascular Pharmacology and Therapeutics

1074-2484

Published by: SAGE

https://journals.sagepub.com/home/cpt

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1719 49 48 15

Additional Metrics

Number of Best Scientists*: 56
Documents by Best Scientists*: 52
Top 100 Ranked Scientists*: 3
SCIMAGO H-index: 60
SCIMAGO SJR: 0.858
Impact Factor: 2.8

Overview

Top Research Topics at Journal of Cardiovascular Pharmacology and Therapeutics?

Journal of Cardiovascular Pharmacology and Therapeutics is mainly concerned with subjects like Internal medicine, Cardiology, Endocrinology, Pharmacology and Anesthesia. Studies in Internal medicine and In patient are the key highlights in it. Journal of Cardiovascular Pharmacology and Therapeutics links adjacent topics like Cardiology with Clinical trial.

Endocrinology study tackled is connected to the field of Receptor. Infarction is a key component of Myocardial infarction research discussed in Journal of Cardiovascular Pharmacology and Therapeutics. Sinus rhythm is a focus of the Atrial fibrillation works in Journal of Cardiovascular Pharmacology and Therapeutics.

The work on Ischemia presented in Journal of Cardiovascular Pharmacology and Therapeutics focuses on Reperfusion injury in particular.

  • Internal medicine (67.17%)
  • Cardiology (43.54%)
  • Endocrinology (19.84%)

What are the most cited papers published in the journal?

  • Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1 (174 citations)
  • Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model: (150 citations)
  • Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy. (145 citations)

Research areas of the most cited articles at Journal of Cardiovascular Pharmacology and Therapeutics:

The journal publications investigate studies in Internal medicine, Cardiology, Endocrinology, Pharmacology and Ischemia. The journal publications focus on Cardiology but the discussions also offer insight into other areas such as Anesthesia and Blood pressure. The Pharmacology research presented in the journal publications focuses mostly on Clopidogrel and, on occasion, topics in Platelet aggregation inhibitor and Platelet activation.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Enzyme
  • Myocardial infarction

The previous edition focused in particular on these issues:

Journal of Cardiovascular Pharmacology and Therapeutics was organized to reinforce research efforts on Internal medicine, Cardiology, In patient, Pharmacology and Myocardial infarction. The work on Internal medicine addressed in it expands to the thematically related Endocrinology. In addition to Cardiology research, it aims to explore topics under Meta-analysis and Vitamin k.

The presented Pharmacology research focuses mostly on Nitric oxide and, on occasion, topics in Pulmonary hypertension. While Heart failure is the focus of it, it also provided insights into the studies of Obesity and Hospitalized patients. Intensive care medicine research featured in it incorporates concerns from various other topics such as Disease and Drug.

The most cited articles from the last journal are:

  • COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management. (19 citations)
  • Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data (10 citations)
  • Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Cardiovascular Pharmacology and Therapeutics (based on the number of publications) are:

  • Robert A. Kloner (49 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Bramah N. Singh (45 papers) absent at the last edition,
  • Jawahar L. Mehta (27 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Moses Elisaf (23 papers) absent at the last edition,
  • Rohit Arora (18 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Cardiovascular Pharmacology and Therapeutics (based on the number of publications) are:

  • University of Southern California (67 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • University of California, Los Angeles (58 papers) absent at the last edition,
  • University of Ioannina (27 papers) absent at the last edition,
  • Cedars-Sinai Medical Center (27 papers) absent at the last edition,
  • Brigham and Women's Hospital (24 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.76% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 4.35% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.25% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.14% of all publications and 78.26% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in the Field of Cardiovascular Pharmacology and Therapeutics

While the Journal of Cardiovascular Pharmacology and Therapeutics is a rich source of knowledge for those involved in research and academia, it is also greatly insightful for individuals interested in pursuing a career in related fields. Studies in Internal medicine, Cardiology, Endocrinology, Pharmacology, and Anesthesia, as highlighted in this journal, offer several career paths in drug development, clinical research, patient care, and medical education. For instance, those who focus on Pharmacology could explore opportunities as a Clinical Pharmacologist. In such a role, professionals apply their understanding of medicines and their effects to treat specific conditions—often aligning with cutting-edge developments in Cardiovascular Pharmacology. Similarly, health professionals trained in Internal Medicine and Cardiology could consider a career as a Cardiology Nurse, tasked with providing pre- and post-operative care to patients undergoing heart surgeries or those dealing with cardiovascular diseases. Moreover, the state of Georgia offers numerous educational programs for individuals seeking to break into this field. To learn more about one such opportunity, you can read this guide on {how to become a registered nurse in Georgia online}. These diverse career paths contribute significantly to healthcare and medicinal progress, reinforcing the importance of the studies presented in the Journal of Cardiovascular Pharmacology and Therapeutics.

Top Publications

  • Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19.

    Husam M. Salah;Jawahar L. Mehta

    (2021)
    34 Citations
  • Novel Antiplatelet Agents in Cardiovascular Disease.

    Maximilian Tscharre;Alan D Michelson;Thomas Gremmel

    (2020)
    34 Citations
  • The Role of Pyroptosis in Ischemic and Reperfusion Injury of the Heart.

    Sergey V Popov;Leonid N Maslov;Natalia V Naryzhnaya;Alexandr V Mukhomezyanov

    (2021)
    33 Citations
  • Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder.

    Himanshu Sankrityayan;Ajinath Kale;Nisha Sharma;Hans Joachim Anders

    (2020)
    29 Citations
  • Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes

    Emir M Muzurović;Snežana Vujošević;Dimitri P Mikhailidis;Dimitri P Mikhailidis

    (2021)
    27 Citations
  • Risks of Cardiovascular Disease and Beyond in Prescription of Nonsteroidal Anti-Inflammatory Drugs

    (2020)
    25 Citations
  • Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.

    Peng Chen;Fen Yang;Wenya Wang;Xiao Li

    (2021)
    24 Citations
  • Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men.

    William B White;Adrian Dobs;Culley Carson;Anthony DelConte

    (2021)
    22 Citations
  • Remote Ischemic Conditioning in Acute Myocardial Infarction and Shock States.

    Robert A Kloner;Robert A Kloner;Jianru Shi;Jianru Shi;Wangde Dai;Wangde Dai;Juan Carreno

    (2020)
    22 Citations
  • Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways:

    Stacy Mandras;Gabor Kovacs;Horst Olschewski;Meredith Broderick

    (2021)
    21 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical knowledge beyond traditional medicine, exploring related online degrees offers flexible options. Many healthcare professionals consider advancing their careers by pursuing nursing degrees, which can open doors to various specialized roles.

Understanding how many years to become a nurse practitioner is essential for planning your education path effectively. Depending on prior qualifications, the timeline can vary significantly.

For registered nurses looking to boost their credentials quickly, a 6 month rn to bsn program can provide a fast track to earning a Bachelor of Science in Nursing, combining convenience with comprehensive training.

Those with an Associate Degree in Nursing might consider bridge options like the adn to fnp pathway, enabling them to become Family Nurse Practitioners, a role in high demand nationwide.

For non-nurses seeking entry into advanced nursing, online direct entry msn programs for non-nurses offer a direct and accelerated route to graduate nursing degrees without prior nursing experience.

Exploring these programs can provide valuable alternatives and complement a medical career in the USA, emphasizing flexibility and career growth within the healthcare sector.

Best Scientists Contributing to This Journal

Recently Published Articles